Navigation Links
Supercomputing research opens doors for drug discovery
Date:12/9/2010

OAK RIDGE, Tenn., Dec. 9, 2010 -- A quicker and cheaper technique to scan molecular databases developed at the Department of Energy's Oak Ridge National Laboratory could put scientists on the fast track to developing new drug treatments.

A team led by Jerome Baudry of the University of Tennessee-ORNL Center for Molecular Biophysics adapted a widely used existing software to allow supercomputers such as ORNL's Jaguar to sift through immense molecular databases and pinpoint chemical compounds as potential drug candidates.

The research was published in the Journal of Computational Chemistry as "Task-parallel MPI implementation of Autodock4 for docking of very large databases of compounds using High Performance Super-Computers."

"Our research is the missing link between supercomputers and the huge data available in molecular databases like the Human Genome Project," Baudry said. "We have an avalanche of data available to us, and now we need to translate that data into knowledge."

Such translation is critical for the first stages of drug development, in which researchers look for appropriate chemicals that interact with a target in the body, typically a protein. If the chemical is suitable, it attaches onto the protein and produces a desirable effect in the cell.

But with thousands of known proteins and millions of chemicals as potential drugs, the number of possible combinations is astronomical.

"It is very expensive and time-consuming to measure these interactions experimentally," Baudry said. "But with supercomputers, we can process millions of molecules a day."

The quick and efficient processing of molecules offers scientists an opportunity to take risks on previously unexamined drug candidates, which could lead to diverse and innovative classes of drugs.

"Before, we threw away a lot of information because molecules did not have a preferred profile," Baudry said. "Now, every molecule can be examined without worrying about wasting resources."

The researchers have already started work to launch the research into reality through a new collaboration supported by the National Institutes of Health. The project team plans to put the computational development to work on ORNL supercomputers to look for chemicals that could treat prostate cancer. The research is funded by a NIH Clinical Translational Science Award, which was awarded to Georgetown and Howard Universities and includes ORNL, Med/Star Health and the Washington D.C. Veterans Affairs Medical Center as key partners.

"Our development work is the computational equivalent of building the Saturn V rocket," Baudry said. "Now we want to fly it to the moon."


'/>"/>

Contact: Morgan McCorkle
mccorkleml@ornl.gov
865-574-7308
DOE/Oak Ridge National Laboratory
Source:Eurekalert

Related biology news :

1. Argonne scientists awarded supercomputing time to enable scientific breakthroughs
2. New standard proposed for supercomputing
3. Defense-scale supercomputing comes to alternative energy research
4. DOE awards over a billion supercomputing hours to address scientific challenges
5. PNNL researchers earn top honors at Supercomputing conference
6. Researcher develops accurate method for detecting dangerous fluoride
7. Isogenic cell models for cancer research exclusively licensed to Horizon Discovery
8. Researchers discover how natural drug fights inflammation
9. States now fund majority of human embryonic stem cell research
10. Genetic studies of human evolution win researcher 2011 Gani Medal
11. Researchers devise computer model for projecting severity of flu season
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
Breaking Biology News(10 mins):
(Date:5/23/2016)... , May 23, 2016 Zimmer Biomet Holdings, Inc. ... today announced that its Board of Directors has approved the ... second quarter of 2016. The cash dividend ... July 29, 2016 to stockholders of record as of the ... dividends are subject to approval of the Board of Directors ...
(Date:5/23/2016)... CA (PRWEB) , ... May 23, 2016 , ... ... public interest organization focused on molecular nanotechnology, announced the winners for the 2015 ... pioneer physicist Richard Feynman, are given in two categories, one for experiment and ...
(Date:5/20/2016)... ... May 20, 2016 , ... Korean researchers say Manumycin A triggers apoptosis, ... new way to treat the disease. Surviving Mesothelioma has just posted an article on ... several Korean institutions based their mesothelioma study on the fact the Manumycin A, a ...
(Date:5/19/2016)... There is no saying when ... relentless pressures in pricing and lack in consumer confidence. ... though - numerous opportunities are up for grabs but ... presents four names in this sector: Portola Pharmaceuticals Inc. ... VTAE ), Anthera Pharmaceuticals Inc. (NASDAQ: ...
Breaking Biology Technology: